A new daily pill, daraxonrasib, is being hailed as a potential game-changer in the treatment of pancreatic cancer, one of the most aggressive and challenging forms of the disease. Early medical trials have shown remarkable results, with the drug, when combined with chemotherapy, appearing to shrink and even eliminate tumors in a significant number of […]